Advancing Targeted Immunotherapy for Cancer Research
Empowering researchers with over 80 locally-produced antibodies and advanced lab services. Padza is revolutionizing cancer diagnostics and treatment with cutting-edge immunotherapy solutions.
Driving Impact in Cancer Research and Treatment
Padza is a knowledge-based biotechnology company committed to advancing cancer research, non-invasive diagnosis, and treatment using targeted immunotherapy. By producing high-quality monoclonal and polyclonal antibodies, apoptosis kits, and specialized laboratory services, we provide researchers with the right tools to solve key challenges such as drug resistance, cancer recurrence, and metastasis.
Padza’s products and services are critical in:
- Identifying diagnostic and therapeutic targets.
- Researching metastasis and cancer relapse mechanisms.
- Analyzing drug resistance pathways.
- Developing innovative cancer immunotherapies.
Leading Supplier of Antibodies
Padza offers an extensive range of research, diagnostic, and therapeutic antibodies, including monoclonal, polyclonal, and conjugated antibodies. Our Hybridoma Bank, housing over 200 cell lines, produces high-quality antibodies tailored to researchers’ diverse needs.
Padza has the capability to produce any antibody against protein antigens and small molecules and toxins. The basis for the production of antibodies against proteins is the use of synthetic peptides derived from protein sequences.
- Monoclonal Antibodies – Highly specific antibodies for research, diagnosis and therapy.
- Polyclonal Antibodies – Broad-spectrum applications for research and diagnostic applications.
- Fluorescence-Conjugated Antibodies – conjugates for advanced imaging.
- Enzyme-Conjugated Antibodies – HRP conjugates for precision analysis.
- Apoptosis Kits – Comprehensive tools for studying programmed cell death.
Comprehensive Lab Services for Cancer Research and Diagnostics
Our state-of-the-art laboratory facilities provide specialized lab services to complement our antibody products:
- Flow Cytometry – Quantitative analysis of cell populations.
- Microscopic Imaging – Precision visualization of cellular activities.
- Antibody Services – Humanizing mouse antibodies and conducting preclinical tests.
- Cell Culture Services – High-quality culturing for cancer and immunology research.
- Apoptosis Assays – Programmed cell death studies.
- ELISA Testing – High-sensitivity antigen-antibody interaction analysis.
Trusted by Leading Institutions
We proudly collaborate with prominent academic and research centers, including:
- Iran University of Medical Sciences
- Tehran University of Medical Sciences
- Shahid Beheshti University
- Pasteur Institute
- Royan Cancer Research Institutes
- Ibn Sina Research Institute
- And others
Why Choose Padza?
Our commitment to advancing cancer immunotherapy and diagnostics has earned the trust of universities, pharmaceutical companies, and medical research institutions worldwide. Here’s why Padza is your trusted partner in cancer research and diagnostics:
Meet the Visionary Behind Padza
With over 20 years of experience, Dr. Rabbani has spearheaded antibody research and established Padza as a leader in targeted cancer immunotherapy.
Dr. Rabbani is a distinguished researcher and thought leader in cancer immunotherapy, focusing on novel antibody development and non-invasive diagnostic techniques. With a career spanning over 30 years, his work bridges research innovation and clinical application, improving outcomes for cancer patients worldwide.
Stay Updated on Cancer Research
Explore Padza’s contributions to cancer immunotherapy:
- Case studies highlighting research breakthroughs.
- Scientific articles published in peer-reviewed journals.
- Blog featuring insights into cancer diagnostics and treatment innovations.
Subscribe to Our Newsletter
Let’s Work Together to Beat Cancer
Explore our library of articles, latest studies, and scientific publications to keep informed about advancements in cancer immunotherapy and diagnostics.